E-Newsletter - December 2019


The San Antonio Breast Cancer Symposium (SABCS) provides state-of-the-art information on breast cancer research. SABCS is a five-day program attended by a broad international audience of academic and private researchers and physicians from more than 90 countries. Its goal is to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication and education for a wide spectrum of researchers, health professionals and those with a special interest in breast cancer. The Alliance for Clinical Trials in Oncology was well represented at the 42nd Annual Meeting December 10-14.

Here's a snapshot of studies that were presented.
Alliance A011203
Alliance A011203: A Randomized Phase II Trial of Tamoxifen Versus Z-endoxifen HCL in Postmenopausal Women with Metastatic Estrogen Receptor Positive, HER2 Negative Breast Cancer
Lead author: Matthew P. Goetz, MD
Abstract #: PD7.06

CALGB (Alliance) 40603
Mutational Analysis of Triple-Negative Breast Cancer (TNBC): CALGB 40603 (Alliance)
Lead author: Katherine A. Hoadley, MD
Abstract #: P4-05-03

CALGB (Alliance) 40903
Musculoskeletal Side Effects Over Time and the Association of Side Effects and Adherence in Women Taking Neoadjuvant Letrozole for Estrogen Receptor Positive DCIS (CALGB 40903)
Lead author: Gretchen Kimmick, MD
Abstract #: P5-14-17



For other articles in this issue of the Alliance E-News newsletter, see below.